Annexon biosciences to present at the 23rd annual needham virtual healthcare conference

Brisbane, calif., april 03, 2024 (globe newswire) -- annexon, inc. (nasdaq: annx), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today announced that douglas love, president and chief executive officer, will participate in a fireside chat at the 23rd annual needham virtual healthcare conference on wednesday, april 10, 2024 at 11:00 a.m. et.
ANNX Ratings Summary
ANNX Quant Ranking